Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.98 USD | -1.48% | -11.51% | -50.03% |
02/05 | Earnings Flash (MODV) MODIVCARE Reports Q1 Revenue $684.5M, vs. Street Est of $663.9M | MT |
03/04 | ModivCare Inc.(NasdaqGS:MODV) dropped from S&P Composite 1500 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.49 for the 2024 fiscal year.
- The company has a low valuation given the cash flows generated by its activity.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- The group shows a rather high level of debt in proportion to its EBITDA.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-50.03% | 317M | C- | ||
+14.10% | 81.84B | C+ | ||
-30.15% | 70.69B | B- | ||
+9.37% | 29.03B | C+ | ||
-11.90% | 16.97B | B | ||
-0.36% | 16.83B | A- | ||
-1.12% | 15.28B | A- | ||
+5.90% | 12.41B | A- | ||
+35.78% | 12.26B | B- | ||
-4.20% | 11.86B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MODV Stock
- Ratings ModivCare Inc.